1. Mondal I#, Das O#, Sun R, Gao J, Yu B, Diaz A, Behnan J, Dubey A, Meng Z, Eskandar E, Xu B, Lu O.R*, Ho W.S*. PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING-Type I Interferon Signaling in Glioblastoma. Cancer Res. 2023 Aug doi: 10.1158/0008-5472.CAN-22-3382. PMID: 37219874.
JIF(2023) 11.2
2. Hu Y#, Jiang Y#, Behnan J, Ribeiro M.M, Kalantzi C, Zhang M, Lou D, Häring M, Sharma N, Okawa S, Del Sol A, Adameyko I, Mikael Svensson M, Persson O, and Ernfors P. Neural-network learning defines glioblastoma features to be of neural crest perivascular or radial glia lineages. Science Adv 2022 Jun. doi: 10.1126/sciadv.abm6340.
JIF(2023) 17.5
3. Guo M*, Goudarzi K, Abedi S, Pieber M, Behnan J, Sjöberg E, Zhang X.M, Ernfors P, Harris R.A, Bartek J, Lindström M, Nistér M, Hägerstrand D*. SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma. Oncogene (2021). https://doi.org/10.1038
JIF(2023) 8.8
4. Behnan J*, Finocchiaro G, Hanna G. The Landscape of Mesenchymal Signature in Brain tumors. Brain: a journal of neurology 2019 142;4 847-866
*Corresponding author
JIF(2023) 14.5
5. Behnan J*, Stangeland B, Langella T, Finocchiaro G, Tringali G, Meling T, Murrell W. Identification and Characterization of New Source of Adult Human Neural Progenitors. Cell Death and Disease (2017) 8, e2991; doi:10.1038/cddis.2017.368.
*Corresponding author
JIF(2023) 9.69
6. Behnan J*, Stangeland B, Hosainey SA, Joel M, Olsen TK, Micci F, Glover JC, Isakson P, Brinchmann JE (2017). Differential propagation of stroma and cancer stem cells dictates tumorigenesis and multipotency. Oncogene, 36 (4), 570-584. PubMed 27345406.
*Corresponding author
JIF(2023) 8.8
7. Behnan J*, Stangeland B, Langella T, Finocchiaro G, Murrell W, Brinchmann JE (2016)
Ultrasonic Surgical Aspirate is a Reliable Source For Culturing Glioblastoma Stem Cells
Sci Rep, 6, 32788. PubMed 27605047.
*Corresponding author
JIF(2023) 4.996
8. Behnan J*, Isakson P, Joel M, Cilio C, Langmoen IA, Vik-Mo EO, Badn W (2014)
Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression
Stem Cells, 32 (5), 1110-23. PubMed 24302539.
*Corresponding author
JIF(2023) 5.8
9. Fayzullin A, Tuvnes FA, Skjellegrind HK, Behnan J, Mughal AA, Langmoen IA, Vik-Mo EO (2016). Time-lapse phenotyping of invasive glioma cells ex vivo reveals subtype-specific movement patterns guided by tumor core signaling. Exp Cell Res, 349 (2), 199-213. PubMed 27515001
JIF(2023) 4.15
10. Behnan J, Grieg Z, Joel M, Ramsness I and Stangeland B*. Gene knockdown of CENPA reduces sphere forming ability and stemness of glioblastoma initiating cells. Neuroepigenetics 7, (2016) 6-18
JIF(2023) 2.64
11. Joel M, Mughal AA, Grieg Z, Murrell W, Palmero S, Mikkelsen B, Fjerdingstad HB, Sandberg CJ, Behnan J, Glover JC, Langmoen IA, Stangeland B (2015). Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo. Mol Cancer, 14, 121. PubMed 26081429
JIF(2023) 37.3
12. Sandberg CJ, Vik-Mo EO, Behnan J, Helseth E, Langmoen IA (2014). Transcriptional profiling of adult neural stem-like cells from the human brain PLoS One, 9 (12), e114739. PubMed 25514637
JIF(2023) 3.75